Vivonics was recently awarded a $225,000 Small Business Innovation Research (SBIR) contract from the NIH to develop SympTMM, Symptomatic Toxicity Mobile Monitor.

In this Phase I research, Vivonics plans to develop and validate a new mobile application to monitor the symptomatic toxicities and health-related quality of life of cancer patients who are undergoing and have undergone radiation therapy during the course of their treatment.

Dr. Ryan Myers of Vivonics will be acting as Principal Investigator for this project.